
Associations between immune-suppressive and stimulating drugs and novel COVID-19 — a systematic review of current evidence
Cancer and transplant patients with COVID-19 have a higher risk of developing severe and even fatal respiratory diseases, especially as they may be treated with immune-suppressive or immune-stimulating drugs. This review focuses on the effects of these drugs on host immunity against COVID-19.
Read More